Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis

Urushitani, Makoto, Sik, Attila, Sakurai, Takashi, Nukina, Nobuyuki, Takahashi, Ryosuke, Julien, Jean-Pierre·2006·Nature Neuroscience
DOI 10.1038/nn1603

Cited by (418)

Items 101–200 of 418

  1. Endoplasmic Reticulum Stress in Motor Neurons of the Spinal Cord in Sporadic Amyotrophic Lateral Sclerosis
    Sasaki, Shoichi · 2010 · Journal of Neuropathology & Experimental Neurology
  2. Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment
    Gerald Goodall, Karen E. Morrison · 2006 · Expert Reviews in Molecular Medicine
  3. IL-10 Controls Early Microglial Phenotypes and Disease Onset in ALS Caused by Misfolded Superoxide Dismutase 1
    Gravel, Mathieu, Béland, Louis-Charles, Soucy, Geneviève, Abdelhamid, Essam, Rahimian, Reza, Gravel, Claude, Kriz, Jasna · 2016 · The Journal of Neuroscience
  4. Expression of Amyotrophic Lateral Sclerosis-linked SOD1 Mutant Increases the Neurotoxic Potential of Microglia via TLR2
    Yang Liu, Wenlin Hao, Alik Dawson, Shirong Liu, Klaus C Fassbender · 2008 · Journal of Biological Chemistry
  5. Peptide Fingerprinting of Alzheimer's Disease in Cerebrospinal Fluid: Identification and Prospective Evaluation of New Synaptic Biomarkers
    Holger Jahn, Stefan Wittke, Petra Zürbig, Thomas J. Raedler, Sönke Arlt, Markus Kellmann, William Mullen, Martin Eichenlaub, Harald Mischak, Klaus Wiedemann · 2011 · PLoS ONE
  6. Structural Properties and Interaction Partners of Familial ALS-Associated SOD1 Mutants
    Jisen Huai, Zhongjian Zhang · 2019 · Frontiers in Neurology
  7. Toll‐like receptors in neuroinflammation, neurodegeneration, and alcohol‐induced brain damage
    María Pascual, María Calvo-Rodríguez, Lucı́a Núñez, Carlos Villalobos, Juán Ureña, Consuelo Guerri · 2021 · IUBMB Life
  8. Gamma motor neurons survive and exacerbate alpha motor neuron degeneration in ALS
    Mélanie Lalancette–Hébert, Aarti Sharma, Alexander K. Lyashchenko, Neil A. Shneider · 2016 · Proceedings of the National Academy of Sciences
  9. Astrocytes expressing mutant SOD1 and TDP43 trigger motoneuron death that is mediated via sodium channels and nitroxidative stress
    Fabiola Rojas, Nicole Cortés, Sebastián Abarzúa, Agnieszka Dyrda, Brigitte van Zundert · 2014 · Frontiers in Cellular Neuroscience
  10. Extracellular Vesicles in Brain Tumors and Neurodegenerative Diseases
    Ciregia, Federica, Urbani, Andrea, Palmisano, Giuseppe · 2017 · Frontiers in Molecular Neuroscience
  11. Adeno-associated Virus–mediated Delivery of a Recombinant Single-chain Antibody Against Misfolded Superoxide Dismutase for Treatment of Amyotrophic Lateral Sclerosis
    Priyanka Patel, Jasna Križ, Mathieu Gravel, Geneviève Soucy, Christine Bareil, Claude Gravel, Jean‐Pierre Julien · 2014 · Molecular Therapy
  12. Calcium homeostasis in aging neurons
    Vassiliki Nikoletopoulou, Nektarios Tavernarakis · 2012 · Frontiers in Genetics
  13. Mutant SOD1-expressing astrocytes release toxic factors that trigger motoneuron death by inducing hyperexcitability
    Elsa Fritz, Pamela Izaurieta, Alexandra Weiss, Franco Rafael Mir, Patricio Rojas, David González, Fabiola Rojas, Robert H. Brown, Rodolfo Madrid, Brigitte van Zundert · 2013 · Journal of Neurophysiology
  14. SOD1 mutations in amyotrophic lateral sclerosis
    Stefania Battistini, F. Giannini, Giuseppe Greco, G. Bibbò, Loretta Ferrera, Valéria Marini, R. Causarano, Mattia Casula, Giuliana Lando, Maria Cristina Patrosso et al. · 2005 · Journal of Neurology
  15. Prions and the Potential Transmissibility of Protein Misfolding Diseases
    Allison Kraus, Bradley R. Groveman, Byron W. Caughey · 2013 · Annual Review of Microbiology
  16. Absence of Tumor Necrosis Factor-α Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutations
    Genevíève Gowing, Florence Dequen, Geneviève Soucy, Jean‐Pierre Julien · 2006 · Journal of Neuroscience
  17. Extracellular aggregated Cu/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype
    Kate Roberts, Rafaa Zeineddine, Lisa Corcoran, Wen Li, Iain Leslie Campbell, Justin J. Yerbury · 2012 · Glia
  18. The effect of music and multimodal stimulation on responses of premature infants in neonatal intensive care.
    Jayne M. Standley · 1998 · PubMed
  19. An enhanced integrated stress response ameliorates mutant SOD1-induced ALS
    Lijun Wang, Brian Popko, Raymond P. Roos · 2013 · Human Molecular Genetics
  20. ER Dysfunction and Protein Folding Stress in ALS
    Soledad Matus, Vicente Valenzuela, Danilo B. Medinas, Claudio A. Hetz · 2013 · International Journal of Cell Biology
  21. Stress signaling from the endoplasmic reticulum: A central player in the pathogenesis of amyotrophic lateral sclerosis
    Adam K. Walker, Julie D. Atkin · 2011 · IUBMB Life
  22. Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis
    Cédric Boucherie, Sabrina Schäfer, Patricia M. Lavand'homme, Jean‐Marie Maloteaux, Emmanuel Hermans · 2009 · Journal of Neuroscience Research
  23. Pathogenic superoxide dismutase structure, folding, aggregation and turnover
    Peter John Hart · 2006 · Current Opinion in Chemical Biology
  24. Non‐neuronal Cells in ALS: Role of Glial, Immune cells and Blood‐CNS Barriers
    Fabìola Puentes, Andrea Malaspina, Johannes M. van Noort, Sandra Amor · 2016 · Brain Pathology
  25. In vitro study of axonal migration and myelination of motor neurons in a three‐dimensional tissue‐engineered model
    Marie Gingras, Marie‐Michèle Beaulieu, Vicky Gagnon, Heather D. Durham, François Berthod · 2007 · Glia
  26. Biomarker-based dissection of neurodegenerative diseases
    Bob Olsson, Henrik Zetterberg, Harald Juergen Hampel, Kaj Blennow · 2011 · Progress in Neurobiology
  27. Reduced Calreticulin Levels Link Endoplasmic Reticulum Stress and Fas-Triggered Cell Death in Motoneurons Vulnerable to ALS
    Nathalie Bernard‐Marissal, Anice Moumen, Claire Sunyach, Christophe Pellegrino, Keith Dudley, Christopher E. Henderson, Cédric Raoul, Brigitte Pettmann · 2012 · Journal of Neuroscience
  28. Reactive oxygen species trigger motoneuron death in non-cell-autonomous models of ALS through activation of c-Abl signaling
    Fabiola Rojas, David González, Nicole Cortés, Estíbaliz Ampuero, Diego E. Hernández, Elsa Fritz, Sebastián Abarzúa, Alexis N. Martinez, Álvaro A. Elorza, Alejandra R. Alvarez et al. · 2015 · Frontiers in Cellular Neuroscience
  29. Aberrant molecular properties shared by familial Parkinson’s disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1
    Tomohiro Kabuta, Rieko Setsuie, Takeshi Mitsui, Aiko Kinugawa, Mikako Sakurai, Shunsuke Aoki, Kenko Uchida, Keiji Wada · 2008 · Human Molecular Genetics
  30. MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis
    Jihong Kang, Serge Rivest · 2007 · The Journal of Cell Biology
  31. Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
    Federica Rizzo, Giulietta Maria Riboldi, Sabrina Salani, Monica Nizzardo, Chiara Simone, Stefania Paola Corti, Eva Hedlund · 2013 · Cellular and Molecular Life Sciences
  32. Toll-like receptors in central nervous system injury and disease: A focus on the spinal cord
    Adee Heiman, Alexandra Pallottie, Robert F. Heary, Stella Elkabes · 2014 · Brain Behavior and Immunity
  33. Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis
    Juan Carlos Corona, Luis B. Tovar‐y‐Romo, Ricardo Tapia · 2007 · Expert Opinion on Therapeutic Targets
  34. Protein interaction networks in neurodegenerative diseases: From physiological function to aggregation
    Gaetano Calabrese, Cristen M. Molzahn, Thibault Mayor · 2022 · Journal of Biological Chemistry
  35. Amyotrophic lateral sclerosis: update and new developments
    J. Jefferson P. Perry, Ashley J. Pratt, Getzoff · 2012 · Degenerative Neurological and Neuromuscular Disease
  36. Inflammation, Immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology
    Miles S. Lyon, Marlena Wosiski‐Kuhn, Rachel Gillespie, James B. Caress, Carol Milligan · 2018 · Muscle & Nerve
  37. The biophysics of superoxide dismutase-1 and amyotrophic lateral sclerosis
    Gareth S. A. Wright, S.V. Antonyuk, S.S. Hasnain · 2019 · Quarterly Reviews of Biophysics
  38. The endoplasmic reticulum‐Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS
    Makoto Urushitani, Samer Abou Ezzi, Akinori Matsuo, Ikuo Tooyama, Jean‐Pierre Julien · 2008 · The FASEB Journal
  39. Starvation and inhibition of lysosomal function increased tau secretion by primary cortical neurons
    Nguyen‐Vi Mohamed, Vanessa Plouffe, Gaudeline Rémillard‐Labrosse, Emmanuel Planel, Nicole M. Leclerc · 2014 · Scientific Reports
  40. The neurobiology of amyotrophic lateral sclerosis
    André Bento‐Abreu, Philip Van Damme, Ludo Van Den Bosch, Wim Robberecht · 2010 · European Journal of Neuroscience
  41. Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis
    Debora Giunti, Benedetta Parodi, Christian Cordano, Antonio Uccelli, Nicole Kerlero de Rosbo · 2013 · Immunology
  42. The multifaceted role of glial cells in amyotrophic lateral sclerosis
    Chiara F. Valori, Liliana Brambilla, Francesca Martorana, Daniela Rossi · 2013 · Cellular and Molecular Life Sciences
  43. Induction of Protective Immunity by Vaccination With Wild-Type Apo Superoxide Dismutase 1 in Mutant SOD1 Transgenic Mice
    Shigeko Takeuchi, Noriko Fujiwara, Akemi Ido, Miki Oono, Yuki Takeuchi, Minako Tateno, Keiichiro Suzuki, Ryosuke Takahashi, Ikuo Tooyama, Naoyuki Taniguchi et al. · 2010 · Journal of Neuropathology & Experimental Neurology
  44. Excessive release of inorganic polyphosphate by ALS/FTD astrocytes causes non-cell-autonomous toxicity to motoneurons
    Cristián Arredondo, Carolina Cefaliello, Agnieszka Dyrda, Nur Jury, Pablo Martínez, Iván Darío Parrado Díaz, Armando Amaro, Hélène Tran, Danna Morales, Marı́a Pertusa et al. · 2022 · Neuron
  45. Rat Neuropeptidomics by LC−MS/MS and MALDI−FTMS: Enhanced Dissection and Extraction Techniques Coupled with 2D RP-RP HPLC
    James A. Dowell, William Vander Heyden, Lingjun Li · 2006 · Journal of Proteome Research
  46. Mitochondria and endoplasmic reticulum crosstalk in amyotrophic lateral sclerosis
    Giovanni Manfredi, Hibiki Kawamata · 2015 · Neurobiology of Disease
  47. Proteostasis impairment in ALS
    Céline Ruegsegger, Smita Saxena · 2016 · Brain Research
  48. Monocyte migration: A novel effect and signaling pathways of catestatin
    Margot Egger, Arno G. E. Beer, Markus Theurl, Wilfried Schgoer, Benjamin A. Hotter, T. Tatarczyk, Danijela Vasiljevic, Silke Frauscher, Josef Marksteiner, Josef R. Patsch et al. · 2008 · European Journal of Pharmacology
  49. Selective Expression of Osteopontin in ALS-resistant Motor Neurons is a Critical Determinant of Late Phase Neurodegeneration Mediated by Matrix Metalloproteinase-9
    Yuta Morisaki, Mamiko Niikura, Mizuho Watanabe, Kosuke Onishi, Shogo Tanabe, Yasuhiro Moriwaki, Takashi Okuda, Shinji Ohara, Shigeo Murayama, Masaki Takao et al. · 2016 · Scientific Reports
  50. A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis
    Marcel Maier, Tobias Welt, Fabian Wirth, Fabio Montrasio, Daniel F. Preisig, Jordan McAfoose, Fernando G. Vieira, Luka Kulic, Claudia B. Späni, Thilo Stehle et al. · 2018 · Science Translational Medicine
  51. Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis
    Eiichi Tokuda, Yo-ichi Takei, Shinji Ohara, Noriko Fujiwara, Isao Hozumi, Yoshiaki Furukawa · 2019 · Molecular Neurodegeneration
  52. Mutant SOD 1 inhibits ER ‐Golgi transport in amyotrophic lateral sclerosis
    Julie D. Atkin, Manal A. Farg, Kai Ying Soo, Adam K. Walker, Mark A. Halloran, Bradley J. Turner, Phillip Nagley, Malcolm Kenneth Horne · 2013 · Journal of Neurochemistry
  53. Strong P2X4 purinergic receptor‐like immunoreactivity is selectively associated with degenerating neurons in transgenic rodent models of amyotrophic lateral sclerosis
    Anna Casanovas, Sara Hernández, Olga Tarabal, Jaume Rosselló, Josep Enric Esquerda · 2007 · The Journal of Comparative Neurology
  54. Interleukin 4 modulates microglia homeostasis and attenuates the early slowly progressive phase of amyotrophic lateral sclerosis
    Rossi, Chiara, Cusimano, Melania, Zambito, Martina, Finardi, Annamaria, Capotondo, Alessia, Garcia-Manteiga, Jose Manuel, Comi, Giancarlo, Furlan, Roberto, Martino, Gianvito, Muzio, Luca · 2018 · Cell Death & Disease
  55. From molecule to molecule and cell to cell: Prion-like mechanisms in amyotrophic lateral sclerosis
    Leslie I. Grad, Sarah M. Fernando, Neil R. Cashman · 2015 · Neurobiology of Disease
  56. ALS: astrocytes move in as deadly neighbors
    Jean‐Pierre Julien · 2007 · Nature Neuroscience
  57. The roles of intrinsic disorder-based liquid-liquid phase transitions in the “Dr. Jekyll–Mr. Hyde” behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration
    Vladimir Nikolaevich Uversky · 2017 · Autophagy
  58. Golgi Fragmentation in ALS Motor Neurons. New Mechanisms Targeting Microtubules, Tethers, and Transport Vesicles
    Georg Haase, Cathérine Rabouille · 2015 · Frontiers in Neuroscience
  59. Proteostatic imbalance and protein spreading in amyotrophic lateral sclerosis
    M.E. Cicardi, Lara Marrone, Mimoun Azzouz, Davide Trotti · 2021 · The EMBO Journal
  60. The dual roles of immunity in ALS: Injury overrides protection
    Benjamin J. Murdock, Diane E. Bender, Benjamin M. Segal, Eva L. Feldman · 2015 · Neurobiology of Disease
  61. Prion-like activity of Cu/Zn superoxide dismutase
    Leslie I. Grad, Neil R. Cashman · 2014 · Prion
  62. Glia cells in amyotrophic lateral sclerosis: New clues to understanding an old disease?
    Clemens Neusch, Mathias Bähr, Christiane Schneider‐Gold · 2007 · Muscle & Nerve
  63. Dysregulation of intracellular copper trafficking pathway in a mouse model of mutant copper/zinc superoxide dismutase‐linked familial amyotrophic lateral sclerosis
    Eiichi Tokuda, Eriko Okawa, Shin‐ichi Ono · 2009 · Journal of Neurochemistry
  64. Chromogranin B Regulates Calcium Signaling, Nuclear Factor κB Activity, and Brain Natriuretic Peptide Production in Cardiomyocytes
    Felix Matthias Heidrich, Kun Zhang, Manuel Estrada, Yan Huang, Frank J. Giordano, Barbara E. Ehrlich · 2008 · Circulation Research
  65. Misfolded superoxide dismutase‐1 in CSF from amyotrophic lateral sclerosis patients
    Per Zetterström, Peter Munch Andersen, Thomas Brännström, Stefan L. Marklund · 2011 · Journal of Neurochemistry
  66. Generalization of the Prion Hypothesis to Other Neurodegenerative Diseases: An Imperfect Fit
    Will C. Guest, Judith M. Silverman, Edward Pokrishevsky, Megan A. O’Neill, Leslie I. Grad, Neil R. Cashman · 2011 · Journal of Toxicology and Environmental Health
  67. Motor neuron trophic factors: Therapeutic use in ALS?
    Thomas W. Gould, Ronald W. Oppenheim · 2010 · Brain Research Reviews
  68. Dynamic changes of CX3CL1/CX3CR1 axis during microglial activation and motor neuron loss in the spinal cord of ALS mouse model
    Jingjing Zhang, Yufei Liu, Xinyao Liu, Song Li, Cheng Cheng, Sheng Chen, Weidong Le · 2018 · Translational Neurodegeneration
  69. Amyotrophic Lateral Sclerosis: New Insights into Underlying Molecular Mechanisms and Opportunities for Therapeutic Intervention
    Mauro Cozzolino, Maria Grazia Pesaresi, Valeria Gerbino, Julian Großkreutz, Maria Teresa Carrı̀ · 2012 · Antioxidants and Redox Signaling
  70. Biological effects of CCS in the absence of SOD1 enzyme activation: implications for disease in a mouse model for ALS
    Jody B. Proescher, Marjatta Son, Jeffrey L. Elliott, Valeria Culotta · 2008 · Human Molecular Genetics
  71. Retromer stabilization results in neuroprotection in a model of Amyotrophic Lateral Sclerosis
    Luca Muzio, Riccardo Sirtori, Davide Gornati, Simona Eleuteri, Andrea Fossaghi, Diego Brancaccio, Leonardo Manzoni, Linda Ottoboni, Luca De Feo, Angelo Quattrini et al. · 2020 · Nature Communications
  72. Axonal ligation induces transient redistribution of TDP-43 in brainstem motor neurons
    Sato, T., Takeuchi, S., Saito, A., Ding, W., Bamba, H., Matsuura, H., Hisa, Y., Tooyama, I., Urushitani, M. · 2009 · Neuroscience
  73. Early-Stage Treatment with Withaferin A Reduces Levels of Misfolded Superoxide Dismutase 1 and Extends Lifespan in a Mouse Model of Amyotrophic Lateral Sclerosis
    Priyanka Patel, Jean‐Pierre Julien, Jasna Križ · 2014 · Neurotherapeutics
  74. In Vivo Imaging Reveals Distinct Inflammatory Activity of CNS Microglia versus PNS Macrophages in a Mouse Model for ALS
    Payam Dibaj, Heinz Steffens, Jana Zschüntzsch, Fabien Nadrigny, Eike Dieter Schomburg, Frank Kirchhoff, Clemens Neusch · 2011 · PLoS ONE
  75. Interaction between -Synuclein and Other Proteins in Neurodegenerative Disorders
    K. A. Jellinger · 2011 · The Scientific World JOURNAL
  76. Potential Effect of S-Nitrosylated Protein Disulfide Isomerase on Mutant SOD1 Aggregation and Neuronal Cell Death in Amyotrophic Lateral Sclerosis
    Gye Sun Jeon, Tomohiro Nakamura, Jeong-Seon Lee, Won-Jun Choi, Suk‐Won Ahn, Kwang‐Woo Lee, Jung‐Joon Sung, Stuart A. Lipton · 2013 · Molecular Neurobiology
  77. Cellular calcium signaling in the aging brain
    Chandran Remya, Mantosh Kumar, Lakshmi Kesavan, Reena Sarah Jacob, Sowmya Gunasekaran, Sethu Lakshmi, Chittalakkottu Sadasivan, R.V. Omkumar · 2017 · Journal of Chemical Neuroanatomy
  78. Molecular Signatures of Amyotrophic Lateral Sclerosis Disease Progression in Hind and Forelimb Muscles of an SOD1 G93A Mouse Model
    Daniele Capitanio, Michele Vasso, Antonia Ratti, Giuliano Grignaschi, Manuela Volta, Manuela Moriggi, Cristina Daleno, Caterina Bendotti, Vincenzo Silani, Cecilia Gelfi · 2012 · Antioxidants and Redox Signaling
  79. Granins as disease-biomarkers: translational potential for psychiatric and neurological disorders
    Alessandro Bartolomucci, Giulio Maria Pasinetti, Stephen R. Salton · 2010 · Neuroscience
  80. Amyotrophic lateral sclerosis pathogenesis: a journey through the secretory pathway
    Nassif, Melissa, Matus, Soledad, Castillo, Karen, Hetz, Claudio · 2010 · Antioxidants & Redox Signaling
  81. The regulation of exosome function in the CNS: implications for neurodegeneration
    Properzi, Francesca, Ferroni, Elena, Poleggi, Anna, Vinci, Ramona · 2015 · Swiss Medical Weekly
  82. Involvement of NOX1/NADPH Oxidase in Morphine-Induced Analgesia and Tolerance
    Masakazu Ibi, Kuniharu Matsuno, Misaki Matsumoto, Mika Sasaki, Takayuki Nakagawa, Masato Katsuyama, Kazumi Iwata, Jia Zhang, Shuji Kaneko, Chihiro Yabe‐Nishimura · 2011 · Journal of Neuroscience
  83. Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis
    François Gros‐Louis, Peter Munch Andersen, Nicolas Dupré, Makoto Urushitani, Patrick A. Dion, F Souchon, Monique L. D'Amour, William Camu, Vincent Meininger, Jean-Pierre Bouchard et al. · 2009 · Proceedings of the National Academy of Sciences
  84. Proteostasis and Movement Disorders: Parkinson's Disease and Amyotrophic Lateral Sclerosis
    Daryl A. Bosco, M. J. LaVoie, Gregory A. Petsko, Dagmar Ringe · 2011 · Cold Spring Harbor Perspectives in Biology
  85. Cerebrospinal fluid–based kinetic biomarkers of axonal transport in monitoring neurodegeneration
    Patrizia Fanara, Po‐yin Anne Wong, Kristofor H. Husted, Shanshan Liu, Victoria M. Liu, Lori A. Kohlstaedt, Timothy J. Riiff, Joan Protasio, Drina Boban, Salena Killion et al. · 2012 · Journal of Clinical Investigation
  86. Protective effects of Withania somnifera extract in SOD1G93A mouse model of amyotrophic lateral sclerosis
    Dutta, Kallol, Patel, Priyanka, Julien, Jean-Pierre · 2018 · Experimental Neurology
  87. Voltage-Dependent Sodium Channels in Spinal Cord Motor Neurons Display Rapid Recovery From Fast Inactivation in a Mouse Model of Amyotrophic Lateral Sclerosis
    Cristina Zona, Massimo Pieri, Irene Carunchio · 2006 · Journal of Neurophysiology
  88. Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling
    Dutta, Kallol, Thammisetty, Sai Sampath, Boutej, Hejer, Bareil, Christine, Julien, Jean-Pierre · 2020 · The Journal of Neuroscience
  89. Time course of oxidant markers and antioxidant defenses in subgroups of amyotrophic lateral sclerosis patients
    Emanuela Cova, Paolo Bongioanni, Cristina Cereda, Maria Rita Metelli, Laura Salvaneschi, Stefano Bernuzzi, Stefania Guareschi, Bruno Rossi, Mauro Ceroni · 2010 · Neurochemistry International
  90. Motor neuron–immune interactions: the vicious circle of ALS
    Ana G. Barbeito, Pinar Mesci, Séverine Boillée · 2010 · Journal of Neural Transmission
  91. Macrophage colony stimulating factor (M-CSF) exacerbates ALS disease in a mouse model through altered responses of microglia expressing mutant superoxide dismutase
    Gowing, Genevieve, Lalancette-Hébert, Mélanie, Audet, Jean-Nicolas, Dequen, Florence, Julien, Jean-Pierre · 2009 · Experimental Neurology
  92. Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact
    Fabiola De Marchi, Ivana Munitić, Amedeo Amedei, James D. Berry, Eva L. Feldman, Eleonora Aronica, Giovanni Nardo, Donatienne Van Weehaeghe, Elena Niccolai, Nikolina Prtenjača et al. · 2021 · Neuroscience & Biobehavioral Reviews
  93. Nanomaterials as Microglia Modulators in the Treatment of Central Nervous System Disorders
    Matteo Battaglini, Attilio Marino, Margherita Montorsi, Alessio Carmignani, Maria Cristina Ceccarelli, Gianni Ciofani · 2023 · Advanced Healthcare Materials
  94. Astrocytes in amyotrophic lateral sclerosis: direct effects on motor neuron survival
    Kim A. Staats, Ludo Van Den Bosch · 2009 · Journal of Biological Physics
  95. Targeted Multiple Reaction Monitoring Analysis of CSF Identifies UCHL1 and GPNMB as Candidate Biomarkers for ALS
    Shaochun Zhu, Anna Wuolikainen, Junfang Wu, Anders Öhman, Gunnar Wingsle, Thomas Möritz, Peter Munch Andersen, Lars Forsgren, Miles Trupp · 2019 · Journal of Molecular Neuroscience
  96. Physical Activity and Neuroprotection in Amyotrophic Lateral Sclerosis
    Mary McCrate, Brian K. Kaspar · 2008 · NeuroMolecular Medicine
  97. Protein disulfide isomerase-immunopositive inclusions in patients with amyotrophic lateral sclerosis
    Yasuyuki Honjo, Satoshi Kaneko, Hidefumi Ito, Tomohisa Horibe, Masato Nagashima, Masataka Nakamura, Kengo Fujita, Ryōsuke Takahashi, Hirofumi Kusaka, Koji Kawakami · 2011 · Amyotrophic Lateral Sclerosis
  98. Stathmin 1/2-triggered microtubule loss mediates Golgi fragmentation in mutant SOD1 motor neurons
    Sarah Bellouze, Gilbert Baillat, Dorothée Buttigieg, Pierre de la Grange, Cathérine Rabouille, Georg Haase · 2016 · Molecular Neurodegeneration
  99. The role of glia in protein aggregation
    Qingyun Li, Michael Seamus Haney · 2020 · Neurobiology of Disease
  100. Monitoring CSF Proteome Alterations in Amyotrophic Lateral Sclerosis: Obstacles and Perspectives in Translating a Novel Marker Panel to the Clinic
    Nils v. Neuhoff, Tonio Oumeraci, Thomas A. Wolf, Katja Kollewe, Peter Bewerunge, Boris Neumann, Benedikt Brors, Johannes Bufler, Ulrich Wurster, Brigitte Schlegelberger et al. · 2012 · PLoS ONE